Adult acute lymphoblastic leukemia (ALL) is biologically heterogeneous and can be subdivided into several clinico-prognostic entities.1 The primary distinction is between B-cell and T-cell precursor (BCP, TCP) ALL, and in the former group between Philadelphia chromosome/BCR-ABL (Ph) positive and Ph− ALL. Here, ABL1 is linked to acute lymphoblastic leukemia.